Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


resTORbio
501 Boylston Street, Suite 6102
Boston, MA 02116
Phone: 617-482-2333
https://www.restorbio.com/

resTORbio is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio's lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caused by immunosenescence, the decline in immune function that occurs during aging.

Key Contact
NameTitleE-Mail
Chen SchorPresident and CEOcschor@restorbio.com


Funding Events
DateAmountTypeInvestors
11/30/17$40,000,000Series B Fidelity Management & Research Company
Nest.Bio Ventures
OrbiMed Advisors  
Quan Capital
Rock Springs Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.